Expressed on CD8+ T, NK, and CD4+ T cells, CXCR6 could promote the recruitment of tumor-infiltrating lymphocytes in combination with CXCL16 expressed by tumor cells, thus contributing to a better prognosis for cancer patients [17]. The gene discussed is CXCL16; the disease is cancer.